Life Science

Ipilimumab (Yervoy) is a humanized monoclonal antibody that is approved by the U.S.

Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S.

Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S.

Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S.

Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S.

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.